Home
Guide
Picks
High Yield
Dates
Monthly
Screener
Resources
ESG
Retire
Channels
Continue to site >
Trending ETFs
You take care of your investments. We like that.
Upgrade to Premium to access your Watchlist and more.
Or Login to Your Premium Account

The Health Care Select Sector SPDR Fund

ETF
XLV
Payout Change
Pending
Price as of:
$146.87 -1.25 -0.84%
primary theme
Health Care Sector Equity
XLV (ETF)

The Health Care Select Sector SPDR Fund

Payout Change
Pending
Price as of:
$146.87 -1.25 -0.84%
primary theme
Health Care Sector Equity
XLV (ETF)

The Health Care Select Sector SPDR Fund

Payout Change
Pending
Price as of:
$146.87 -1.25 -0.84%
primary theme
Health Care Sector Equity

Name

As of 10/31/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

The Health Care Select Sector SPDR Fund

XLV | ETF

$146.87

$38.4 B

1.57%

$2.31

0.09%

Vitals

YTD Return

8.9%

1 yr return

19.5%

3 Yr Avg Return

4.8%

5 Yr Avg Return

11.0%

Net Assets

$38.4 B

Holdings in Top 10

56.6%

52 WEEK LOW AND HIGH

$148.1
$125.52
$157.24

Expenses

OPERATING FEES

Expense Ratio 0.09%

SALES FEES

Front Load N/A

Deferred Load N/A

TRADING FEES

Turnover 4.00%

Redemption Fee N/A

Min Investment

Standard (Taxable)

N/A

IRA

N/A

Fund Classification

Fund Type

Exchange Traded Fund

Name

As of 10/31/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

The Health Care Select Sector SPDR Fund

XLV | ETF

$146.87

$38.4 B

1.57%

$2.31

0.09%

XLV - Profile

Distributions

  • YTD Total Return 8.9%
  • 3 Yr Annualized Total Return 4.8%
  • 5 Yr Annualized Total Return 11.0%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio 1.54%
DIVIDENDS
  • Dividend Yield 1.6%
  • Dividend Distribution Frequency Quarterly

Fund Details

  • Legal Name
    The Health Care Select Sector SPDR Fund
  • Fund Family Name
    State Street Global Advisors - advised funds
  • Inception Date
    Dec 22, 1998
  • Shares Outstanding
    298615324
  • Share Class
    N/A
  • Currency
    USD
  • Domiciled Country
    US
  • Manager
    Michael Feehily

Fund Description

In seeking to track the performance of the Index, the Fund employs a replication strategy, which means that the Fund typically invests in substantially all of the securities represented in the Index in approximately the same proportions as the Index.
Under normal market conditions, the Fund generally invests substantially all, but at least 95%, of its total assets in the securities comprising the Index. The Fund will provide shareholders with at least 60 days' notice prior to any material change in this 95% investment policy. In addition, the Fund may invest in cash and cash equivalents or money market instruments, such as repurchase agreements and money market funds (including money market funds advised by SSGA Funds Management, Inc. (“SSGA FM” or the “Adviser”), the investment adviser to the Fund).
The Index includes companies that have been identified as Health Care companies by the Global Industry Classification Standard (GICS®), including securities of companies from the following industries: pharmaceuticals; health care equipment and supplies; health care providers and services; biotechnology; life sciences tools and services; and health care technology. The Index is one of eleven Select Sector Indexes developed and maintained in accordance with the following criteria: (1) each of the component securities in the Index is a constituent of the S&P 500 Index; and (2) the Index is calculated by S&P Dow Jones Indices LLC (“S&P DJI”) based on a proprietary “modified market capitalization” methodology which means that modifications may be made to the market capitalization weights of single stock concentrations in order to conform to the requirements of the Internal Revenue Code of 1986, as amended (the “Internal Revenue Code” or “IRC”). As of November 30, 2023, the Index was composed of 64 stocks.
The Index is also sponsored and compiled by S&P DJI. S&P DJI determines the composition of the Index and relative weightings of the securities in the Index based on the Index methodology (as the “Index Compilation Agent”). S&P DJI also publishes information regarding the market value of the Index (as the “Index Provider”). S&P DJI is not affiliated with the Fund or the Adviser.
Read More

XLV - Performance

Return Ranking - Trailing

Period XLV Return Category Return Low Category Return High Rank in Category (%)
YTD 8.9% -29.5% 23.3% 52.83%
1 Yr 19.5% -0.3% 57.6% 76.10%
3 Yr 4.8%* -33.0% 11.0% 14.47%
5 Yr 11.0%* -4.9% 13.7% 16.44%
10 Yr 9.9%* 0.1% 13.3% 7.21%

* Annualized

Return Ranking - Calendar

Period XLV Return Category Return Low Category Return High Rank in Category (%)
2023 0.4% -12.6% 19.0% 68.55%
2022 -3.6% -53.9% 3.2% 9.21%
2021 24.2% -39.6% 24.2% 0.66%
2020 11.4% -13.6% 178.2% 59.73%
2019 17.7% 3.8% 63.8% 74.44%

Total Return Ranking - Trailing

Period XLV Return Category Return Low Category Return High Rank in Category (%)
YTD 8.9% -29.5% 23.3% 52.83%
1 Yr 19.5% -0.3% 57.6% 76.10%
3 Yr 4.8%* -33.0% 11.0% 14.47%
5 Yr 11.0%* -4.9% 13.7% 16.44%
10 Yr 9.9%* 0.1% 13.3% 7.21%

* Annualized

Total Return Ranking - Calendar

Period XLV Return Category Return Low Category Return High Rank in Category (%)
2023 2.1% -12.6% 19.0% 79.25%
2022 -2.1% -53.9% 3.7% 11.84%
2021 26.0% -33.9% 26.0% 0.66%
2020 13.3% -0.7% 180.6% 81.88%
2019 20.4% 4.6% 63.8% 84.96%

XLV - Holdings

Concentration Analysis

XLV Category Low Category High XLV % Rank
Net Assets 38.4 B 6.87 M 47.2 B 1.89%
Number of Holdings 65 26 430 68.55%
Net Assets in Top 10 22.1 B 2.12 M 22.1 B 0.63%
Weighting of Top 10 56.55% 18.4% 79.7% 15.72%

Top 10 Holdings

  1. Eli Lilly Co 13.43%
  2. UnitedHealth Group Inc 8.71%
  3. Johnson Johnson 6.54%
  4. Merck Co Inc 5.83%
  5. AbbVie Inc 5.63%
  6. Thermo Fisher Scientific Inc 3.92%
  7. Abbott Laboratories 3.36%
  8. Amgen Inc 3.12%
  9. Danaher Corp 3.06%
  10. Pfizer Inc 2.95%

Asset Allocation

Weighting Return Low Return High XLV % Rank
Stocks 		99.86% 87.34% 106.13% 12.58%
Cash 		0.25% 0.00% 33.01% 86.16%
Preferred Stocks 		0.00% 0.00% 7.86% 52.20%
Other 		0.00% -22.99% 23.24% 56.60%
Convertible Bonds 		0.00% 0.00% 0.37% 36.36%
Bonds 		0.00% 0.00% 12.39% 49.69%

Stock Sector Breakdown

Weighting Return Low Return High XLV % Rank
Healthcare 		100.00% 59.26% 100.00% 16.88%
Utilities 		0.00% 0.00% 0.00% 32.47%
Technology 		0.00% 0.00% 22.69% 38.96%
Real Estate 		0.00% 0.00% 5.89% 36.36%
Industrials 		0.00% 0.00% 7.02% 37.66%
Financial Services 		0.00% 0.00% 1.60% 51.95%
Energy 		0.00% 0.00% 0.00% 32.47%
Communication Services 		0.00% 0.00% 9.11% 35.71%
Consumer Defense 		0.00% 0.00% 25.73% 40.91%
Consumer Cyclical 		0.00% 0.00% 1.92% 37.66%
Basic Materials 		0.00% 0.00% 7.16% 53.90%

Stock Geographic Breakdown

Weighting Return Low Return High XLV % Rank
US 		99.86% 66.06% 104.41% 10.06%
Non US 		0.00% 0.00% 28.87% 74.21%

XLV - Expenses

Operational Fees

XLV Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 0.09% 0.08% 4.48% 99.37%
Management Fee 0.03% 0.03% 1.25% 0.63%
12b-1 Fee 0.02% 0.00% 1.00% 15.58%
Administrative Fee N/A 0.03% 0.25% N/A

Sales Fees

XLV Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 3.50% 5.75% N/A
Deferred Load N/A 1.00% 1.00% N/A

Trading Fees

XLV Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 1.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

XLV Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 4.00% 0.00% 238.00% 5.19%

XLV - Distributions

Dividend Yield Analysis

XLV Category Low Category High XLV % Rank
Dividend Yield 1.57% 0.00% 6.24% 18.87%

Dividend Distribution Analysis

XLV Category Low Category High Category Mod
Dividend Distribution Frequency Quarterly Annual Annual Annual

Net Income Ratio Analysis

XLV Category Low Category High XLV % Rank
Net Income Ratio 1.54% -2.54% 1.85% 1.97%

Capital Gain Distribution Analysis

XLV Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Annually Annually

Distributions History

View More +

XLV - Fund Manager Analysis

Managers

Michael Feehily

Start Date

Tenure

Tenure Rank

Jan 31, 2011

11.34

11.3%

Mr. Feehily, CFA, is a Managing Director of SSGA and the Adviser and Co-Head of Passive Equity Strategies in North America in the Global Equity Beta Solutions Group. In this capacity, Mr. Feehily has oversight of the North American Passive Equity teams in Boston and Montreal. In addition, Mr. Feehily is a member of the Senior Management Group. Mr. Feehily rejoined SSgA in 2010 after spending the previous four years at State Street Global Markets LLC where he helped to build the Exposure Solutions business.

Karl Schneider

Start Date

Tenure

Tenure Rank

Jan 31, 2015

7.33

7.3%

Karl Schneider, CAIA, is a Vice President of SSGA and SSGA FM, and Head of U.S. Equity Strategies for GEBS, where in addition to overseeing the management of the U.S. equity index strategies, he also serves as a portfolio manager for a number of the group's passive equity portfolios. Previously within GEBS, he served as a portfolio manager and product specialist for synthetic beta strategies, including commodities, buy/write, and hedge fund replication. Prior to joining GEBS, Mr. Schneider worked as a portfolio manager in SSGA's Currency Management Group, managing both active currency selection and traditional passive hedging overlay portfolios. He joined SSGA in 1996. Mr. Schneider holds a BS in finance and investments from Babson College and an MS in finance from Boston College. He has earned the Chartered Alternative Investment Analyst designation. Mr. Schneider is a member of the CAIA Association.

Dwayne Hancock

Start Date

Tenure

Tenure Rank

Jan 03, 2017

5.41

5.4%

Dwayne Hancock, CFA, is a Vice President of SSGA and a Senior Portfolio Manager in the firm’s Global Equity Beta Solutions (GEBS) Group. Within this group, he is currently the strategy leader for the group’s non-U.S.passive products. Prior to taking on this responsibility, Mr. Hancock was the ETF product specialist for the GEBS group. He is also a member of the SSGA Valuation Committee. Mr. Hancock currently manages a varied mix of funds with both domestic and international strategies, which include separate accounts, commingled funds, mutual funds and ETFs. Additionally, he has played a primary role in determining trading strategies for significant benchmark changes such as the annual Russell indices reconstitution. Mr. Hancock joined SSGA in 1996 and became part of the GEBS portfolio management team in 1998. Prior to this, he worked in the firm’s Passive International Equity Operations department as a senior analyst. He has been working in the investment management field since 1994. Mr. Hancock holds a Master of Business Administration from the Carroll School of Management at Boston College and a Bachelor of Science in Business Administration from Framingham State College. He also earned the Chartered Financial Analyst (CFA) designation and is a member of CFA Society Boston, Inc.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.02 24.72 7.88 0.25

Advertisement

×

Wait! Rates are rising, is your portfolio ready?

×